Tobacco cessation within TB programmes: A ‘real world’ solution for countries with dual burden of disease

CORDIS fournit des liens vers les livrables publics et les publications des projets HORIZON.

Les liens vers les livrables et les publications des projets du 7e PC, ainsi que les liens vers certains types de résultats spécifiques tels que les jeux de données et les logiciels, sont récupérés dynamiquement sur OpenAIRE .

Livrables

Project website

To establish a project website

Trial Register - results

Report on status of posting results in the trial register to be submitted at month 42 after completing data analysis and submitting report on the trial

Process eval report -SH

The findings of the process evaluation summarised and tailored to the specific needs of stakeholders

Report on the trial

A comprehensive report on the randomised controlled trial findings

'Way Forward' report

A final report on the recommendations made at the ‘way forward’ workshops

Process eval report - SC

The findings of the process evaluation reported in one or more scientific articles in international peer-reviewed journals

Interventions and Lessons

A summary of all the intervention materials and lessons learnt on implementation and adaptation of the cessation strategies

Delivery factors report

An inventory of factors (barriers and facilitators) that are likely to be influential in the delivery of tobacco cessation within TB programme context

Scaling up budget

A budget impact analysis of scaling up tobacco cessation strategies within TB programmes

Tobacco use scales

A translated and validated suite of tobacco withdrawal symptoms and dependency scales

Economic Analysis Report

Cost-effectiveness analysis report of cytisine when added to behavioural support for tobacco cessation compared to behavioural support alone

All approvals package

'All approvals package’ for the trial including ethics approval letters from the respective national competent authorities, approval letters from respective national TB Programs (Bangladesh, Nepal, Pakistan), and approval letters for exporting and importing pharmacological agent used in the trial to be submitted at month 12 prior to trial recruitment

Outcome factors report

A report on the contextual factors that predicts outcomes, either positively or negatively, and their implications for policy makers and health professionals

Intervention materials

Locally appropriate suite of intervention materials for Bangladesh, Nepal and Pakistan

Publications

Protocol for the mixed-methods process and context evaluation of the TB & Tobacco randomised controlled trial in Bangladesh and Pakistan: a hybrid effectiveness–implementation study

Auteurs: Melanie Boeckmann, Iveta Nohavova, Omara Dogar, Eva Kralikova, Alexandra Pankova, Kamila Zvolska, Rumana Huque, Razia Fatima, Maryam Noor, Helen Elsey, Aziz Sheikh, Kamran Siddiqi, Daniel Kotz
Publié dans: BMJ Open, Numéro 8/3, 2018, Page(s) e019878, ISSN 2044-6055
Éditeur: BMJ Publishing Group
DOI: 10.1136/bmjopen-2017-019878

Measuring fidelity to behavioural support delivery for smoking cessation and its association with outcomes

Auteurs: Omara Dogar, Jan R. Boehnke, Fabiana Lorencatto, Trevor A. Sheldon, Kamran Siddiqi
Publié dans: Addiction, 2019, ISSN 0965-2140
Éditeur: Blackwell Publishing Inc.
DOI: 10.1111/add.14804

Using behaviour change theory to train health workers on tobacco cessation support for tuberculosis patients: a mixed-methods study in Bangladesh, Nepal and Pakistan

Auteurs: Sahil Warsi, Helen Elsey, Melanie Boeckmann, Maryam Noor, Amina Khan, Deepa Barua, Shammi Nasreen, Samina Huque, Rumana Huque, Sudeepa Khanal, Prabin Shrestha, James Newell, Omara Dogar, Kamran Siddiqi
Publié dans: BMC Health Services Research, Numéro 19/1, 2019, ISSN 1472-6963
Éditeur: BioMed Central
DOI: 10.1186/s12913-019-3909-4

Health worker and patient views on implementation of smoking cessation in routine tuberculosis care

Auteurs: Melanie Boeckmann, Sahil Warsi, Maryam Noor, Omara Dogar, Esha Haowa Mustagfira, Fariza Firoze, Raana Zahid, Anne Readshaw, Kamran Siddiqi, Daniel Kotz
Publié dans: npj Primary Care Respiratory Medicine, Numéro 29/1, 2019, ISSN 2055-1010
Éditeur: Nature Publishing Group
DOI: 10.1038/s41533-019-0146-6

H2020 funding for respiratory research: scaling up for the prevention and treatment of lung diseases

Auteurs: Constantine I. Vardavas, Christina N. Kyriakos, Esteve Fernández, Panagiotis Bamidis, Kamran Siddiqi, Niels H. Chavannes, R.M.J.J. van der Kleij, Gary Parker, Cornel Radu-Loghin, Brian Ward, Karim Berkouk
Publié dans: European Respiratory Journal, Numéro 54/3, 2019, Page(s) 1901417, ISSN 0903-1936
Éditeur: European Respiratory Society
DOI: 10.1183/13993003.01417-2019

The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patientsprotocol for a double-blind, placebo-controlled randomized trial

Auteurs: Dogar, Omara Fatima; Barua, Deepa; Boeckmann, Melanie; Elsey, Helen; Fatima, Razia; Gabe, Rhian; Huque, Rumana; Keding, Ada; Khan, Amina; Kotz, Daniel; Kralikova, Eva; Newell, James N; Nohavova, Iveta; Parrott, Steven James; Readshaw, Anne Elizabeth; Renwick, Charlotte; Sheikh, Aziz; Siddiqi, Kamran
Publié dans: urn:issn:0965-2140, Numéro 1, 2018, ISSN 0965-2140
Éditeur: Blackwell Publishing Inc.
DOI: 10.1111/add.14242

Recherche de données OpenAIRE...

Livrables

Publications

Partager cette page

Télécharger